Volume 22, Issue 3, 2022
Is there Cholinesterase Activity in the Eye?
Pp: 151-159
Author(s): Sandra Carolina Durán-Cristiano*
DOI: 10.2174/1871524922666220414093730
Published on: 26 September, 2022
Neuroinflammation: Molecular Mechanisms And Therapeutic Perspectives
Pp: 160-174
Author(s): Marianna Marino, Elena Mele, Grazia Maria Giovanna Pastorino, Rosaria Meccariello*, Francesca Felicia Operto, Antonietta Santoro and Andrea Viggiano
DOI: 10.2174/1871524922666220929153215
Published on: 15 November, 2022
Phyllanthus emblica L. Regulates BDNF/PI3K Pathway to Modulate Glutathione for Mitoprotection and Neuroprotection in a Rodent Model of Ischemic Stroke
Pp: 175-187
Author(s): Deepaneeta Sarmah, Geetesh Verma, Aishika Datta, Namrata Vadak, Antra Chaudhary, Kiran Kalia and Pallab Bhattacharya*
DOI: 10.2174/1871524922666220607093400
Published on: 20 August, 2022
Formulation, Development, and in-vitro Evaluation of Escitalopram Fast Dissolving Tablets
Pp: 198-213
Author(s): Vishal Bhatia, Ashwani K. Dhingra*, Rameshwar Dass, Bhawna Chopra and Kumar Guarve
DOI: 10.2174/1871524922666220624113719
Published on: 21 September, 2022
Ellagic Acid Prevents Oxidative Stress and Memory Deficits in a Rat Model of Scopolamine-induced Alzheimer's Disease
Pp: 214-227
Author(s): Amir Hossein Assaran, Mahsan Akbarian, Sabiheh Amirahmadi, Hossein Salmani, Shima Shirzad, Mahmoud Hosseini, Farimah Beheshti and Arezoo Rajabian*
DOI: 10.2174/1871524923666221027100949
Published on: 15 November, 2022
Acknowledgements to Reviewers
Pp: 228-228
DOI: 10.2174/187152492203221123144926
Published on: 23 November, 2022
Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study
Pp: 188-197
Author(s): Ismail Rammouz*, Mohamed Merzouki, Sara Bouri, Aalouane Rachid, Amine Bout and Saïd Boujraf
DOI: 10.2174/1871524922666220620150033
Published on: 07 September, 2022
